Technical Analysis for ARTL - Artelo Biosciences Inc

Grade Last Price % Change Price Change
grade B 1.21 10.00% 0.1100
ARTL closed up 10.0 percent on Thursday, June 20, 2019, on 8.23 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Up Up
See historical ARTL trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
MACD Bullish Signal Line Cross Bullish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Upper Bollinger Band Touch Strength 0.00%
20 DMA Resistance Bearish 10.00%
50 DMA Resistance Bearish 10.00%
Shooting Star Candlestick Bearish 10.00%

Older signals for ARTL ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Artelo Biosciences, Inc., an ethical biopharmaceutical company, focuses on developing, licensing, and commercializing cannabinoid therapeutic treatments. Its products pipeline includes ART12.11, a cannabidiol composition for the treatment of inflammatory bowel disease, stroke, and rare/orphan diseases; ART26.12, an endocannabinoid transport protein (FABP5) inhibitor for the treatment of breast cancer, prostate cancer, and neuropathic and nociceptive pain; and ART27.13 for the treatment of cancer and cachexia. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was founded in 2011 and is based in La Jolla, California.
Medicine Medical Specialties Branches Of Biology Cancer Pain Treatment Of Cancer Breast Cancer Prostate Cancer Cannabinoid Neurochemistry Stroke Geriatrics Inflammatory Bowel Disease Rehabilitation Medicine Treatment Of Breast Cancer Treatment Of Inflammatory Bowel Disease
Is ARTL a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 2.7
52 Week Low 0.27
Average Volume 3,280
200-Day Moving Average 0.0
50-Day Moving Average 1.1104
20-Day Moving Average 1.125
10-Day Moving Average 1.122
Average True Range 0.174
ADX 18.9
+DI 31.4228
-DI 29.8451
Chandelier Exit (Long, 3 ATRs ) 0.978
Chandelier Exit (Short, 3 ATRs ) 1.322
Upper Bollinger Band 1.2872
Lower Bollinger Band 0.9628
Percent B (%b) 0.76
BandWidth 28.835556
MACD Line -0.0027
MACD Signal Line -0.0063
MACD Histogram 0.0036
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.6600
Resistance 3 (R3) 1.6567 1.5033 1.5850
Resistance 2 (R2) 1.5033 1.3887 1.5050 1.5600
Resistance 1 (R1) 1.3567 1.3179 1.4300 1.3600 1.5350
Pivot Point 1.2033 1.2033 1.2400 1.2050 1.2033
Support 1 (S1) 1.0567 1.0887 1.1300 1.0600 0.8850
Support 2 (S2) 0.9033 1.0179 0.9050 0.8600
Support 3 (S3) 0.7567 0.9033 0.8350
Support 4 (S4) 0.7600